Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Hang

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
World Journal of Clinical Cases|October 17, 2022
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or CJing-Hang Xu, Sa Wang, Da-Zhi Zhang, et al.
Journal of Viral Hepatitis|June 23, 2022
240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or CJing-Hang Xu, Ya-Nan Fan, Yan-Yan Yu, et al.
Food Science & Nutrition|April 8, 2026
Salidroside Ameliorates Polycystic Ovary Syndrome in Mice by Regulating the AKT/NF-κB/NLRP3-HAS2 AxisJing-Hang Li, Shu-Ming Shi, Li-Ying Liu, et al.
Cell Host & Microbe|May 16, 2024
Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signalingXuemei Wang, Shuang Zhou, Xiaomin Hu, et al.
Science (New York, N.Y.)|August 3, 2023
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic targetKai Wang, Zhiwei Zhang, Jing Hang, et al.
Zoological Research|May 20, 2024
Human-like adrenal features in Chinese tree shrews revealed by multi-omics analysis of adrenal cell populations and steroid synthesisJing-Hang Jiang, Yi-Fu Wang, Jie Zheng, et al.
World Journal of Clinical Cases|July 5, 2021
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeksXiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, et al.
Medicine|August 16, 2019
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48Rong-Yue Liang, Jing-Hang Xu, Chong-Wen Si, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
World Journal of Clinical Cases|October 17, 2022
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or CJing-Hang Xu, Sa Wang, Da-Zhi Zhang, et al.
Journal of Viral Hepatitis|June 23, 2022
240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or CJing-Hang Xu, Ya-Nan Fan, Yan-Yan Yu, et al.
Food Science & Nutrition|April 8, 2026
Salidroside Ameliorates Polycystic Ovary Syndrome in Mice by Regulating the AKT/NF-κB/NLRP3-HAS2 AxisJing-Hang Li, Shu-Ming Shi, Li-Ying Liu, et al.
Cell Host & Microbe|May 16, 2024
Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signalingXuemei Wang, Shuang Zhou, Xiaomin Hu, et al.
Science (New York, N.Y.)|August 3, 2023
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic targetKai Wang, Zhiwei Zhang, Jing Hang, et al.
Zoological Research|May 20, 2024
Human-like adrenal features in Chinese tree shrews revealed by multi-omics analysis of adrenal cell populations and steroid synthesisJing-Hang Jiang, Yi-Fu Wang, Jie Zheng, et al.
World Journal of Clinical Cases|July 5, 2021
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeksXiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, et al.
Medicine|August 16, 2019
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48Rong-Yue Liang, Jing-Hang Xu, Chong-Wen Si, et al.
Pageof 16